HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Daniil Stroyakovskiy Xavier Pivot Elżbieta Starosławska |
| Publication date | May 20, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |